北京招聘

Vitrolife is committed to improving pregnancy rates. This is why we provide an unbroken chain of quality products, securing the results in every step during the whole IVF-treatment. Only Vitrolife can guarantee every link in this chain. With equally devoted clinics we reach success. Together. All the way.
History
Vitrolife was founded in 1994 and was one of the first companies to provide IVF-laboratories with high quality ready-to-use culture media.

Vitrolife acquired Swemed, a company manufacturing aspiration needles, catheters and micro pipettes in 2006. Swemed was also one of the pioneers in IVF, inventing the transvaginal follicle aspiration needle with an ultrasound probe already in the 1980s. This technique has since then been used successfully worldwide.

In 2010 Vitrolife acquired Conception Technologies, giving access to more products for micro techniques and andrology.

In 2014 Vitrolife acquired Fertilitech with its product EmbryoScope, to further extend our offer in time-lapse technology.

Research and development
Today we collaborate with several researchers within the field of ART, both universities and clinics. A valuable asset in our research and development is our top of the line development laboratory where we make continuous improvements on the current product line and develop new products.

Quality Control
To us, quality is being passionate about all the details leading up to the most supportive products in the most protective environment for the most viable embryo.

High pregnancy rates depend on numerous factors, some of which are beyond human control. That is why we are devoted to controlling everything that can be controlled in order to achieve high pregnancy rates. This includes every dimension of quality regarding media, instruments and procedures when performing IVF. Consequently our QC tests span from each single LOT of raw material to microscopic inspection of every single micropipette.

Regulatory compliance
Our products are developed with the aim to improve pregnancy rates. Another focus for us is the safety for the patient and the embryologist or gynecologist.

The CE-mark on our products means that they comply with the demands for safety that the European Union’s Medical Device Directive has on this type of products. We have worked for and will continue to insist on the question of the importance of CE marked products becoming a requirement in fertility treatment.

Most of our products have CE-mark, FDA-clearance, TGA-approval as well as approval from SFDA and Canada Health.

World-wide presence
Vitrolife products are available in most parts of the world. For some regions we have direct shipments from one of our distribution sites, and for other sites we are collaborating with dedicated distributors.

Many countries have a Vitrolife local sales representative. You are also always welcome to contact us at one of our main offices at any time. We are present at all major IVF-conferences every year and on most local meetings. See our events calendar for more information.